Mangalam Drugs And Organics Limited

MANGALAM

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202657

    Quarter₹ croreYoY
    Jun 202477-12.5%
    Sept 202480-2.0%
    Dec 202489-8.9%
    Mar 202573-28.6%
    Jun 202557-25.1%
    Sept 202550-38.0%
    Dec 202558-34.1%
    Mar 202667-7.9%
    Jun 202657-0.4%
  • ₹ crore

    Jun 20260.11

    Quarter₹ crore
    Jun 20240.02
    Sept 20240.14
    Dec 20240.13
    Mar 2025-0.13
    Jun 2025<0.01
    Sept 20250.03
    Dec 20250.11
    Mar 20260.09
    Jun 20260.11
  • ₹ crore

    Jun 202657

    Quarter₹ crore
    Jun 202477
    Sept 202480
    Dec 202489
    Mar 202573
    Jun 202557
    Sept 202550
    Dec 202559
    Mar 202667
    Jun 202657
  • Cost structure
  • ₹ crore

    Jun 20269

    Quarter₹ crore
    Jun 202410
    Sept 202410
    Dec 202410
    Mar 202511
    Jun 20259
    Sept 20258
    Dec 20258
    Mar 20268
    Jun 20269
  • ₹ crore

    Jun 202664

    Quarter₹ crore
    Jun 202476
    Sept 202479
    Dec 202487
    Mar 202571
    Jun 202570
    Sept 202562
    Dec 202568
    Mar 202680
    Jun 202664
  • Exceptional items and tax
  • ₹ crore

    Jun 2026-7

    Quarter₹ crore
    Jun 20240.58
    Sept 20241
    Dec 20241
    Mar 20252
    Jun 2025-13
    Sept 2025-12
    Dec 2025-10
    Mar 2026-13
    Jun 2026-7
  • ₹ crore

    Jun 20260.89

    Quarter₹ crore
    Jun 2024-2
    Sept 2024-1
    Dec 20240.08
    Mar 20252
    Jun 20250.80
    Sept 2025-5
    Dec 2025<0.01
    Mar 20260.15
    Jun 20260.89
  • Profit
  • ₹ crore

    Jun 2026-8

    Quarter₹ croreYoY
    Jun 20243+128.2%*
    Sept 20243+175.5%*
    Dec 20241+180.5%
    Mar 20250.15-95.7%
    Jun 2025-14-611.3%
    Sept 2025-7-369.8%
    Dec 2025-10-797.2%
    Mar 2026-13-8755.0%
    Jun 2026-8+45.0%*
  • Per share
  • ₹ per share

    Jun 2026-4.77

    Quarter₹ per share
    Jun 20241.70
    Sept 20241.70
    Dec 20240.89
    Mar 20250.10
    Jun 2025-8.67
    Sept 2025-4.58
    Dec 2025-6.18
    Mar 2026-8.25
    Jun 2026-4.77
  • Leverage
  • Debt to equity

    times

    Dec 20250.00x

    Quartertimes
    Jun 20240.00x
    Sept 2024—
    Dec 2024—
    Mar 2025—
    Jun 2025—
    Sept 2025—
    Dec 20250.00x
    Mar 2026—
    Jun 2026—
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
778089735750586757
Revenue YoY-12.5%-2.0%-8.9%-28.6%-25.1%-38.0%-34.1%-7.9%-0.4%
0.020.140.13-0.13<0.010.030.110.090.11
778089735750596757
Cost structure
1010101198889
767987717062688064
Exceptional items and tax
0.58112-13-12-10-13-7
-2-10.0820.80-5<0.010.150.89
Profit
3310.15-14-7-10-13-8
Net profit YoY+128.2%*+175.5%*+180.5%-95.7%-611.3%-369.8%-797.2%-8755.0%+45.0%*
Per share
1.701.700.890.10-8.67-4.58-6.18-8.25-4.77
Leverage
Debt to equity0.00x—————0.00x——

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.